The Food and Drug Administration announced Thursday that it has reversed its ban on Juul e-cigarettes while it reviews new court decisions and considers updated information provided by the vape-maker.
The FDA first stopped the company from marketing its products in 2022, but they have stayed on shelves pending an appeal.
Even as Juul has pursued its appeal of the 2022 marketing ban, that initial FDA ruling significantly disrupted the company's finances, prompting a bailout from two of its largest investors, The Wall Street Journal has reported.
Juul also continues to face lawsuits from consumers saying its products harmed their health.
To date, the FDA has given only 23 e-cigarette products, made by just three companies, official approval to be marketed to consumers.
Persons:
Juul
Organizations:
Drug Administration, FDA
Locations:
Flatbush, Brooklyn, New York City, U.S